Details of the Drug Formulations

General Information of Drug (ID: DM9PVX8)

Drug Name
Rucaparib Drug Info
Synonyms
RUCAPARIB; 283173-50-2; Rubraca; AG-14447; UNII-8237F3U7EH; 8237F3U7EH; AK317822; 8-Fluoro-1,3,4,5-tetrahydro-2-[4-[(methylamino)methyl]phenyl]-6H-pyrrolo[4,3,2-ef][2]benzazepin-6-one; 8-FLUORO-2-(4-((METHYLAMINO)METHYL)PHENYL)-4,5-DIHYDRO-1H-AZEPINO[5,4,3-CD]INDOL-6(3H)-ONE; 6H-Pyrrolo[4,3,2-ef][2]benzazepin-6-one,8-fluoro-1,3,4,5-tetrahydro-2-[4-[(methylamino)methyl]phenyl]-; 8-fluoro-2-(4-methylaminomethyl-phenyl)-1,3,4,5-tetrahydro-azepino[5,4,3-cd]indol-6-one
Indication
Disease Entry ICD 11 Status REF
Ovarian cancer 2C73 Approved [1]
Cross-matching ID
PubChem CID
9931954
ChEBI ID
CHEBI:94311
CAS Number
283173-50-2
TTD ID
D01SHZ
INTEDE ID
DR1449
ACDINA ID
D00609

Full List of Drug Formulations Containing This Drug

Rucaparib 200 mg tablet
Company Formulation ID FDA Description
Clovis Oncology F19702 Fd&c blue no. 1; Fd&c blue no. 2; Magnesium stearate; Talc; Titanium dioxide; Silicon dioxide; Cellulose, microcrystalline; Polyethylene glycol, unspecified; Polyvinyl alcohol, unspecified; Sodium starch glycolate type a potato
------------------------------------------------------------------------------------
Rucaparib Camsylate eq 200mg base tablet
Company Formulation ID FDA Description
Clovis Oncology F23542 Microcrystalline Cellulose; Sodium Starch Glycolate; Colloidal SiliconDioxide; Magnesium Stearate; Polyvinyl Alcohol; TitaniumDioxide; Polyethylene Glycol/Macrogol; Talc; Brilliant Blue Aluminum Lake; Indigo Carmine Aluminum Lake
------------------------------------------------------------------------------------
Rucaparib Camsylate eq 300mg base tablet
Company Formulation ID FDA Description
Clovis Oncology F23543 Microcrystalline Cellulose; Sodium Starch Glycolate; Colloidal SiliconDioxide; Magnesium Stearate; Polyvinyl Alcohol; TitaniumDioxide; Polyethylene Glycol/Macrogol; Talc; Yellow Iron Oxide
------------------------------------------------------------------------------------
Rucaparib Camsylate eq 250mg base tablet
Company Formulation ID FDA Description
Clovis Oncology F23541 Microcrystalline Cellulose; Sodium Starch Glycolate; Colloidal SiliconDioxide; Magnesium Stearate; Polyvinyl Alcohol; TitaniumDioxide; Polyethylene Glycol/Macrogol; Talc
------------------------------------------------------------------------------------
Rucaparib 300 mg tablet
Company Formulation ID FDA Description
Clovis Oncology F19704 Magnesium stearate; Ferric oxide yellow; Talc; Titanium dioxide; Silicon dioxide; Cellulose, microcrystalline; Polyethylene glycol, unspecified; Polyvinyl alcohol, unspecified; Sodium starch glycolate type a potato
------------------------------------------------------------------------------------
Rucaparib 250 mg tablet
Company Formulation ID FDA Description
Clovis Oncology F19703 Magnesium stearate; Talc; Titanium dioxide; Silicon dioxide; Cellulose, microcrystalline; Polyethylene glycol, unspecified; Polyvinyl alcohol, unspecified; Sodium starch glycolate type a potato
------------------------------------------------------------------------------------

References

1 2016 FDA drug approvals. Nat Rev Drug Discov. 2017 Feb 2;16(2):73-76.